Government Plans Major Overhaul of Tax Administration for Smooth GST Implementation Geopolitical Tensions Rise Fresh US Strikes Complicate Iran Nuclear Deal Negotiations Senegals Government ShakeUp Adds Uncertainty Amid Debt Crisis Waterfield Advisors Equities Head Suggests Staggered Accumulation as Peak Macro Concerns Subside Subramanian Swamy Urges Ban on Cement Imports from Pakistan Citing Smuggling Risks Investment Manager Trims Stock Position Following 80 Surge Since April Frontdoor Inc FTDR Q1 2026 Earnings EPS Surprises to the Upside Amid Steady Operations STRRP Q1 2026 Earnings Significant EPS Miss Raises Concerns for Preferred Shareholders HIND Q1 2026 Earnings EPS Beats Estimates Despite Revenue Absence PXED Q1 2026 Earnings EPS Surges Past Estimates by 656 as BottomLine Strength Defies Broad Market Headwinds TATT Q1 2026 Earnings EPS Surges Past Estimates with 33 Beat MGNX Q1 2026 Earnings Narrowed Loss Meets Street Views Amid Pipeline Progress Pinnacle Financial Partners PNFP Edges Lower Amid Modest Pullback Key Support Levels in Focus US Physical Therapy USPH Gains 332 as Stock Tests Resistance Levels Altria Group Edges Higher as Defensive Positioning Attracts Steady Inflows Erasca Inc ERAS Edges Higher Toward Resistance as Biotech Sector Watches AO Smith AOS Rises 183 as Shares Approach Key Resistance AnheuserBusch InBev Shares Dip as Quarterly Sales Miss Analyst Estimates WEBTOON Entertainment Inc WBTN Q1 2026 Earnings EPS Beat on Cost Discipline Revenue Visibility Remains Limited IHS Holding Limited IHS Holds Steady Near Support as Telecom Infrastructure Stock Consolidates SCM Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance Core Main Inc CNM Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Ceragon Networks Q1 2026 Earnings EPS Beats Estimates as Stock Surges GoodRx Q1 2026 Earnings EPS Misses Estimates Yet Stock Gains 352 Outlook Therapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Surges 29 APPS Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Achieve Life Sciences Q1 2026 Earnings NarrowerthanExpected Loss Drives Optimism